Castle Biosciences Inc (CSTL)
29.81
+0.93
(+3.22%)
USD |
NASDAQ |
Nov 22, 16:00
29.81
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Debt to Equity Ratio: 0.0227 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0227 |
| June 30, 2024 | 0.0236 |
| March 31, 2024 | 0.0248 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.1348 |
| June 30, 2020 | 0.157 |
| March 31, 2020 | 0.2882 |
| December 31, 2019 | 0.2952 |
| September 30, 2019 | 0.3025 |
| June 30, 2019 | -8.102 |
| March 31, 2019 | 11.81 |
| December 31, 2018 | -2.433 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
0.2952
Maximum
Dec 2019
0.0473
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Delcath Systems Inc | 0.2333 |
| Star Equity Holdings Inc | 0.1904 |
| Exact Sciences Corp | 0.80 |
| CytoSorbents Corp | 1.062 |
| Progyny Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 514.56M |
| Total Liabilities (Quarterly) | 73.51M |
| Shareholders Equity (Quarterly) | 441.06M |
| Current Ratio | 7.784 |
| Net Debt Paydown Yield | -0.25% |